Mavoglurant in Alcohol Drinking

What is the purpose of this trial?

The purpose of this alcohol-interaction pilot study is to provide information on the effect of mavoglurant on the pharmacokinetics of alcohol and on alcohol responses, including stimulation, sedation, intoxication, body sway and physiological responses. The investigators propose to test the effects of 200 mg mavoglurant versus placebo on alcohol related responses. This is a between subjects double blind randomized design in which the investigators plan to run 14 subjects to obtain 10 completers.

Participation Guidelines

Ages: 21 - 50 years

Gender: Both

National Institute on Alcohol Abuse and Alcoholism

Start Date: 02/06/2018

End Date: 03/31/2019

Last Updated: 02/22/2018

Study HIC#: 2000021703

Get Involved

For more information about this study, contact:
Nicholas Franco
+1 203-974-7679

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image


Suchitra Krishnan-Sarin

Principal Investigator